肿瘤患者-话题@MedSci

#肿瘤患者#

262篇内容 | 5236人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1424214, encodeId=aa65142421451, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=SCI REP：术前B型钠尿肽前体N末端浓度和脑肿瘤患者的预后相关性分析！, objectType=article, longId=119193, objectId=68f7119193af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68f7119193af, replyNumber=0, likeNumber=71, createdTime=2017-11-09, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68f7119193af, moduleTitle=SCI REP：术前B型钠尿肽前体N末端浓度和脑肿瘤患者的预后相关性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68f7119193af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424213, encodeId=f743142421305, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=2017 临床实践指南：儿童肿瘤患者输注蒽环类药物需持续1小时, objectType=article, longId=118854, objectId=c6f411885436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f411885436, replyNumber=0, likeNumber=25, createdTime=2017-11-07, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f411885436, moduleTitle=2017 临床实践指南：儿童肿瘤患者输注蒽环类药物需持续1小时, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f411885436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424212, encodeId=4cb21424212fd, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=CLIN CANCER RES：DNA修复突变状态不同的肿瘤患者药物毒性反应不同, objectType=article, longId=118508, objectId=a8d1118508d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d1118508d0, replyNumber=0, likeNumber=67, createdTime=2017-11-04, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d1118508d0, moduleTitle=CLIN CANCER RES：DNA修复突变状态不同的肿瘤患者药物毒性反应不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d1118508d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424211, encodeId=221e1424211dd, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=恶性肿瘤患者康复期营养管理专家共识, objectType=article, longId=116860, objectId=2be9116860a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2be9116860a4, replyNumber=0, likeNumber=26, createdTime=2017-10-21, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2be9116860a4, moduleTitle=恶性肿瘤患者康复期营养管理专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2be9116860a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424210, encodeId=ee921424210cb, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性, objectType=article, longId=116540, objectId=d02a116540e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d02a116540e5, replyNumber=0, likeNumber=65, createdTime=2017-10-19, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d02a116540e5, moduleTitle=J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d02a116540e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424209, encodeId=5cc01424209d7, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益, objectType=article, longId=116277, objectId=b63e1162e77c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b63e1162e77c, replyNumber=0, likeNumber=59, createdTime=2017-10-17, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b63e1162e77c, moduleTitle=Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b63e1162e77c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424208, encodeId=acfa142420885, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=如何帮助肿瘤患者调节心理？专家：“同伴教育”非常重要, objectType=article, longId=115517, objectId=885b11551e0f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=885b11551e0f, replyNumber=0, likeNumber=67, createdTime=2017-10-11, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=885b11551e0f, moduleTitle=如何帮助肿瘤患者调节心理？专家：“同伴教育”非常重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=885b11551e0f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424207, encodeId=7e58142420e98, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=36种高价药物进国家医保肿瘤患者将受惠可坚持标准治疗, objectType=article, longId=114704, objectId=637a114e0450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=637a114e0450, replyNumber=0, likeNumber=30, createdTime=2017-09-30, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=637a114e0450, moduleTitle=36种高价药物进国家医保肿瘤患者将受惠可坚持标准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=637a114e0450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424206, encodeId=288b142420613, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, objectType=article, longId=114396, objectId=95c311439626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95c311439626, replyNumber=0, likeNumber=79, createdTime=2017-09-28, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95c311439626, moduleTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95c311439626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424205, encodeId=4413142420542, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=关注肿瘤患者的生存质量——Q-TWiST研究方法在转移性肾癌患者疗效评估中的应用, objectType=article, longId=112105, objectId=93f9112105d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93f9112105d1, replyNumber=0, likeNumber=0, createdTime=2017-09-07, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93f9112105d1, moduleTitle=关注肿瘤患者的生存质量——Q-TWiST研究方法在转移性肾癌患者疗效评估中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93f9112105d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424204, encodeId=2eb4142420448, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则（第五次修订版）, objectType=article, longId=111987, objectId=30ba11198e65, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30ba11198e65, replyNumber=0, likeNumber=32, createdTime=2017-09-06, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30ba11198e65, moduleTitle=血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则（第五次修订版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30ba11198e65)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424203, encodeId=343f14242037d, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JCO：晚期肿瘤患者诊断后1年住院率及再住院预测因素, objectType=article, longId=111349, objectId=b1c011134963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1c011134963, replyNumber=0, likeNumber=96, createdTime=2017-09-01, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1c011134963, moduleTitle=JCO：晚期肿瘤患者诊断后1年住院率及再住院预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1c011134963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424202, encodeId=d971142420294, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=CLIN CANCER RES：头颈部肿瘤患者血浆外泌体抑制淋巴细胞功能, objectType=article, longId=111246, objectId=3e3c111246a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e3c111246a8, replyNumber=0, likeNumber=104, createdTime=2017-08-31, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e3c111246a8, moduleTitle=CLIN CANCER RES：头颈部肿瘤患者血浆外泌体抑制淋巴细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e3c111246a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424201, encodeId=7ede142420192, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Eur Respir J：实体肿瘤和血液系统恶性肿瘤患者结核病的风险！, objectType=article, longId=110846, objectId=fc92110846ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc92110846ac, replyNumber=0, likeNumber=96, createdTime=2017-08-27, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc92110846ac, moduleTitle=Eur Respir J：实体肿瘤和血液系统恶性肿瘤患者结核病的风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc92110846ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424200, encodeId=6ba9142420011, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=CLIN CANCER RES：ABC294640治疗晚期实体肿瘤患者的Ⅰ期临床试验结果, objectType=article, longId=110765, objectId=c218110e6568, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c218110e6568, replyNumber=0, likeNumber=52, createdTime=2017-08-26, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c218110e6568, moduleTitle=CLIN CANCER RES：ABC294640治疗晚期实体肿瘤患者的Ⅰ期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c218110e6568)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424199, encodeId=77651424199e4, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Lancet oncol：用依维莫司治疗的晚期胃肠或肺神经内分泌肿瘤患者的生活质量。, objectType=article, longId=110563, objectId=ad9f11056368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9f11056368, replyNumber=0, likeNumber=73, createdTime=2017-08-24, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9f11056368, moduleTitle=Lancet oncol：用依维莫司治疗的晚期胃肠或肺神经内分泌肿瘤患者的生活质量。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9f11056368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424198, encodeId=8e71142419839, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=X线、CT、MRI 不同肿瘤患者放射诊断选择也不一样, objectType=article, longId=110444, objectId=9a5811044488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a5811044488, replyNumber=0, likeNumber=77, createdTime=2017-08-23, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a5811044488, moduleTitle=X线、CT、MRI 不同肿瘤患者放射诊断选择也不一样, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a5811044488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424197, encodeId=194f142419e35, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=未确定侵袭性真菌病的诊断和治疗：血液病/恶性肿瘤患者侵袭性真菌病的诊断标准和治疗原则解读, objectType=article, longId=110349, objectId=d354110349e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d354110349e7, replyNumber=0, likeNumber=28, createdTime=2017-08-22, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d354110349e7, moduleTitle=未确定侵袭性真菌病的诊断和治疗：血液病/恶性肿瘤患者侵袭性真菌病的诊断标准和治疗原则解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d354110349e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424196, encodeId=3be914241966e, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Leuk Lymphoma：恶性血液肿瘤患者重度血小板减少发生VTE要不要抗凝？, objectType=article, longId=108888, objectId=3e13108888d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e13108888d5, replyNumber=0, likeNumber=54, createdTime=2017-08-17, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e13108888d5, moduleTitle=Leuk Lymphoma：恶性血液肿瘤患者重度血小板减少发生VTE要不要抗凝？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e13108888d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424195, encodeId=869a14241957a, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=人工智能“沃森医生”来上海为肿瘤患者看病了, objectType=article, longId=108328, objectId=fe361083282d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe361083282d, replyNumber=0, likeNumber=54, createdTime=2017-08-11, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe361083282d, moduleTitle=人工智能“沃森医生”来上海为肿瘤患者看病了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe361083282d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤患者

2020-05-29

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

SCI REP：术前B型钠尿肽前体N末端浓度和脑肿瘤患者的预后相关性分析！

2017-11-09

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

2017 临床实践指南：儿童肿瘤患者输注蒽环类药物需持续1小时

2017-11-07

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

CLIN CANCER RES：DNA修复突变状态不同的肿瘤患者药物毒性反应不同

2017-11-04

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

恶性肿瘤患者康复期营养管理专家共识

2017-10-21

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性

2017-10-19

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益

2017-10-17

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

如何帮助肿瘤患者调节心理？专家：“同伴教育”非常重要

2017-10-11

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

36种高价药物进国家医保肿瘤患者将受惠可坚持标准治疗

2017-09-30

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。

2017-09-28

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

关注肿瘤患者的生存质量——Q-TWiST研究方法在转移性肾癌患者疗效评估中的应用

2017-09-07

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则（第五次修订版）

2017-09-06

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JCO：晚期肿瘤患者诊断后1年住院率及再住院预测因素

2017-09-01

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

CLIN CANCER RES：头颈部肿瘤患者血浆外泌体抑制淋巴细胞功能

2017-08-31

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Eur Respir J：实体肿瘤和血液系统恶性肿瘤患者结核病的风险！

2017-08-27

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

CLIN CANCER RES：ABC294640治疗晚期实体肿瘤患者的Ⅰ期临床试验结果

2017-08-26

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Lancet oncol：用依维莫司治疗的晚期胃肠或肺神经内分泌肿瘤患者的生活质量。

2017-08-24

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

X线、CT、MRI 不同肿瘤患者放射诊断选择也不一样

2017-08-23

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

未确定侵袭性真菌病的诊断和治疗：血液病/恶性肿瘤患者侵袭性真菌病的诊断标准和治疗原则解读

2017-08-22

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Leuk Lymphoma：恶性血液肿瘤患者重度血小板减少发生VTE要不要抗凝？

2017-08-17

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

人工智能“沃森医生”来上海为肿瘤患者看病了

2017-08-11

科室
- - 订阅+
  - 更多科室
工具
服务